Intended for healthcare professionals


US public health agency recommends prophylactic doxycycline to reduce STIs

BMJ 2023; 383 doi: (Published 09 October 2023) Cite this as: BMJ 2023;383:p2339
  1. Janice Hopkins Tanne
  1. New York

The US public health agency has proposed that the antibiotic doxycycline is used prophylactically in people at risk of contracting chlamydia, gonorrhoea, and syphilis up to three days after possible exposure.1

The US Centers for Disease Control and Prevention (CDC) said that the preventative action was needed in the face of increasing sexually transmitted infections (STIs). The draft recommendation proposes treatment with doxycycline up to three days after potential exposure. CDC said that this was “a new approach to tackling STI prevention in populations at increased risk.” The groups for whom treatment was an option included young people; gay, bisexual, and other men who have sex with men; pregnant women; transgender …

View Full Text

Log in

Log in through your institution


* For online subscription